Results 9,061-9,080 of 21,780 for speaker:Alan Kelly

Intoxicating Liquor (Breweries and Distilleries) Bill 2016: Report Stage (Resumed) and Final Stage (5 Jul 2018)

Alan Kelly: To be fair, the Minister is a supporter of the breweries. The people involved in the 12 Acres Brewing Company have said so. Having listened to what was discussed on Committee Stage, the breweries and, to be honest, what our colleagues in the House have been telling us, we are trying to improve the legislation. This is a small Bill which I was glad to sponsor. I thank the Minister's...

Intoxicating Liquor (Breweries and Distilleries) Bill 2016: Report Stage (Resumed) and Final Stage (5 Jul 2018)

Alan Kelly: Hear. Hear.

Public Accounts Committee: Business of Committee (5 Jul 2018)

Alan Kelly: We should ask if she will come in next week.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: May I take the same amount of time as did the Chair?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: I was joking. The comment was in jest.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: The witnesses will be delighted to learn I will probably only have time to ask three questions in this round. As of 9 o'clock this morning, how many women have been identified as having been affected? That figure was at 209. It has been reported that the independent review of the cases of 3,000 women will not be completed on schedule and is only commencing now. What is the reason for...

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: As of now, there are 221 women affected.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: Is that figure likely to increase?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: I am just seeking clarification.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: It was not made clear to anyone else.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: This was not communicated----

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: This was not communicated outside of Government.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: Excuse me, my third question has not been answered yet.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: This is ridiculous.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: I thank the Deputy.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: Eighty or 90 women are waiting eight weeks or more.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: How many?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: I have a couple of comments. I find it unbelievable that the witnesses cannot provide the information relating to this protocol today. Why is the protocol being pushed legally, particularly when it is preventing women from getting their slides? Why can some solicitors representing women go into court and get the slides, thereby bypassing this protocol? I do not understand how Mr. Connaghan...

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: I asked for clarification on meetings with Dr. Scally and with the lads in Limerick.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (5 Jul 2018)

Alan Kelly: My other questions relates to the protocol on the slides and the issue of the review of the 3,000 cases, which, I presume, Ms Conroy will answer. The third question relates to the meeting in March 2017 regarding clinical risk and admission of liability.